SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
10-Oct-24 8:38 PM View: | Enliven Therapeutics, Inc. (ELVN) | 09-Oct-24 | Sale (Planned) | 16,710 | $28.15 | $470,405.00 | (2%) 1.02M to 1.0M | |
10-Oct-24 8:38 PM View: | Enliven Therapeutics, Inc. (ELVN) | 08-Oct-24 | Private Sale (Planned) | 13,267 | $27.96 | $370,929.00 | (1%) 1.03M to 1.02M | |
08-Oct-24 6:57 PM View: | Enliven Therapeutics, Inc. (ELVN) | 07-Oct-24 | Sale (Planned) | 2,730 | $27.50 | $75,075.00 | (< 1%) 1.04M to 1.03M | |
08-Oct-24 6:57 PM View: | Enliven Therapeutics, Inc. (ELVN) | 04-Oct-24 | Private Sale (Planned) | 12,206 | $27.51 | $335,792.00 | (1%) 1.05M to 1.04M | |
28-Aug-24 7:48 PM View: | Enliven Therapeutics, Inc. (ELVN) | 26-Aug-24 | Private Sale (Planned) | 12,000 | $22.89 | $274,718.00 | (1%) 1.06M to 1.05M | |
02-Aug-24 7:25 PM View: | Enliven Therapeutics, Inc. (ELVN) | 31-Jul-24 | Private Sale (Planned) | 2,270 | $27.56 | $62,555.10 | (< 1%) 1.06M to 1.06M | |
29-Jul-24 5:39 PM View: | Enliven Therapeutics, Inc. (ELVN) | 25-Jul-24 | Private Sale (Planned) | 12,000 | $24.92 | $299,073.00 | (< 1%) 1.25M to 1.24M | |
27-Jun-24 4:35 PM View: | Enliven Therapeutics, Inc. (ELVN) | 25-Jun-24 | Private Sale (Planned) | 12,000 | $21.66 | $259,902.00 | (< 1%) 1.26M to 1.25M | |
30-May-24 5:56 PM View: | Enliven Therapeutics, Inc. (ELVN) | 28-May-24 | Option Exercise | 12,000 | $1.12 | $13,440.00 | < 1% 1.26M to 1.28M | |
30-May-24 5:56 PM View: | Enliven Therapeutics, Inc. (ELVN) | 28-May-24 | Planned Option Sale | 12,000 | $23.18 | $278,210.00 | (< 1%) 1.28M to 1.26M | |
29-Apr-24 6:50 PM View: | Enliven Therapeutics, Inc. (ELVN) | 25-Apr-24 | Option Exercise | 12,000 | $1.12 | $13,440.00 | < 1% 1.26M to 1.28M | |
29-Apr-24 6:50 PM View: | Enliven Therapeutics, Inc. (ELVN) | 25-Apr-24 | Planned Option Sale | 12,000 | $16.89 | $202,700.00 | (< 1%) 1.28M to 1.26M | |
15-Apr-24 7:05 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Option Exercise | 47,709 | $1.12 | $53,434.10 | 4% 1.26M to 1.31M | |
15-Apr-24 7:05 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Planned Option Sale | 47,709 | $25.04 | $1,194,700.00 | (4%) 1.31M to 1.26M | |
27-Mar-24 5:03 PM View: | Enliven Therapeutics, Inc. (ELVN) | 25-Mar-24 | Option Exercise | 12,000 | $1.12 | $13,440.00 | < 1% 1.26M to 1.28M | |
27-Mar-24 5:03 PM View: | Enliven Therapeutics, Inc. (ELVN) | 25-Mar-24 | Planned Option Sale | 12,000 | $17.56 | $210,661.00 | (< 1%) 1.28M to 1.26M | |
28-Feb-24 10:00 PM View: | Enliven Therapeutics, Inc. (ELVN) | 26-Feb-24 | Option Exercise | 12,000 | $1.12 | $13,440.00 | < 1% 1.26M to 1.28M | |
28-Feb-24 10:00 PM View: | Enliven Therapeutics, Inc. (ELVN) | 26-Feb-24 | Planned Option Sale | 12,000 | $16.89 | $202,653.00 | (< 1%) 1.28M to 1.26M | |
29-Jan-24 8:01 PM View: | Enliven Therapeutics, Inc. (ELVN) | 25-Jan-24 | Option Exercise | 12,000 | $1.12 | $13,440.00 | < 1% 1.26M to 1.28M | |
29-Jan-24 8:01 PM View: | Enliven Therapeutics, Inc. (ELVN) | 25-Jan-24 | Planned Option Sale | 12,000 | $15.69 | $188,230.00 | (< 1%) 1.28M to 1.26M | |
28-Dec-23 4:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 26-Dec-23 | Option Exercise | 12,000 | $1.12 | $13,440.00 | < 1% 1.26M to 1.28M | |
28-Dec-23 4:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 26-Dec-23 | Planned Option Sale | 12,000 | $14.64 | $175,709.00 | (< 1%) 1.28M to 1.26M | |
26-Dec-23 7:31 PM View: | Enliven Therapeutics, Inc. (ELVN) | 22-Dec-23 | Option Exercise | 8,175 | $1.12 | $9,156.00 | < 1% 1.26M to 1.27M | |
26-Dec-23 7:31 PM View: | Enliven Therapeutics, Inc. (ELVN) | 22-Dec-23 | Planned Option Sale | 8,175 | $13.05 | $106,655.00 | (< 1%) 1.27M to 1.26M | |
26-Dec-23 7:31 PM View: | Enliven Therapeutics, Inc. (ELVN) | 21-Dec-23 | Option Exercise | 20 | $1.12 | $22.40 | < 1% 1.26M to 1.26M | |
26-Dec-23 7:31 PM View: | Enliven Therapeutics, Inc. (ELVN) | 21-Dec-23 | Planned Option Sale | 20 | $13.00 | $260.00 | (< 1%) 1.26M to 1.26M | |
21-Dec-23 4:31 PM View: | Enliven Therapeutics, Inc. (ELVN) | 20-Dec-23 | Option Exercise | 7,779 | $1.12 | $8,712.48 | < 1% 1.26M to 1.27M | |
21-Dec-23 4:31 PM View: | Enliven Therapeutics, Inc. (ELVN) | 20-Dec-23 | Planned Option Sale | 7,779 | $13.01 | $101,238.00 | (< 1%) 1.27M to 1.26M | |
06-Nov-23 4:42 PM View: | Enliven Therapeutics, Inc. (ELVN) | 03-Nov-23 | Option Exercise | 8,026 | $1.12 | $8,989.12 | < 1% 1.26M to 1.27M | |
06-Nov-23 4:42 PM View: | Enliven Therapeutics, Inc. (ELVN) | 03-Nov-23 | Planned Option Sale | 8,026 | $13.08 | $104,999.00 | (< 1%) 1.27M to 1.26M | |
26-Sep-23 7:37 PM View: | Enliven Therapeutics, Inc. (ELVN) | 25-Sep-23 | Option Exercise | 12,000 | $1.12 | $13,440.00 | < 1% 1.26M to 1.28M | |
26-Sep-23 7:37 PM View: | Enliven Therapeutics, Inc. (ELVN) | 25-Sep-23 | Planned Option Sale | 12,000 | $13.81 | $165,691.00 | (< 1%) 1.28M to 1.26M | |
27-Feb-23 9:33 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-23 | Grant | 1,264,590 | -- | -- | 100% 0 to 1.26M |